Pulmonx (LUNG) Total Liabilities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Total Liabilities data on file, last reported at $75.2 million in Q4 2025.

• On a quarterly basis, Total Liabilities fell 2.42% year-over-year to $75.2 million in Q4 2025; TTM through Dec 2025 was $75.2 million, a 2.42% decrease from a year earlier, with the FY2025 full-year figure at $75.2 million, down 2.42% from the prior year.
• Total Liabilities for Q4 2025 stood at $75.2 million, down from $78.2 million in the prior quarter.
• Over the last five years, Total Liabilities for LUNG reached as high as $78.2 million in Q3 2025 and fell as low as $38.7 million in Q3 2022.
• Historically, Total Liabilities has averaged $57.0 million across 5 years, with a median of $58.2 million in 2023.
• Across the five-year window, Total Liabilities slumped 37.63% in 2021 and surged 53.08% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $41.9 million in 2021, then fell by 5.4% to $39.7 million in 2022, then jumped by 49.91% to $59.5 million in 2023, then climbed by 29.55% to $77.0 million in 2024, then decreased by 2.42% to $75.2 million in 2025.
• Per Business Quant data, the three most recent Total Liabilities figures were $75.2 million in Q4 2025, $78.2 million in Q3 2025, and $78.1 million in Q2 2025.